Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric Oncology

Cancers
Jérémie Rouger-Gaudichon On Behalf Of Société Française de Lutte Contre Les Cancers Et Leucémies de l'Enfant Et de L'adolescent Sfce

Abstract

Data regarding coronavirus disease 2019 (COVID-19) description are still limited in pediatric oncology. The French society of pediatric oncology (SFCE) initiated a study to better describe COVID-19 in patients followed in French pediatric oncology and hematology wards. All patients diagnosed with COVID-19 and followed in a SFCE center were enrolled. Data from medical records were analyzed for all patients enrolled up to the end of May 2020. Data were available for 37 patients. Thirty-one were children under 18 years of age. Nineteen patients were female. Seventeen patients had a solid tumor, 16 had a hematological malignancy and four recently underwent hematopoietic stem cell transplantation (HSCT) for non-oncological conditions. Twenty-eight patients presented symptoms, most often with fever, cough, rhinorrhea and asthenia. Ground-glass opacities were the most frequent radiological finding with abnormalities mostly bilateral and peripherally distributed. Twenty-four patients received chemotherapy a month prior to COVID-19 diagnosis. Most patients did not require hospitalization. Three patients required oxygen at the time of diagnosis. In total, five patients were admitted in an intensive care unit because of COVID-19 and one d...Continue Reading

References

Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Mar 18, 2020·Pediatrics·Yuanyuan DongShilu Tong
Apr 1, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L ZhangM Zhou
May 7, 2020·Pediatric Blood & Cancer·Monica TerenzianiFilippo Spreafico
May 10, 2020·Pediatric Blood & Cancer·Teresa de RojasLuis Madero
May 14, 2020·JAMA Oncology·Farid BouladAndrew L Kung
Jun 2, 2020·The Lancet Oncology·Liang V Tang, Yu Hu
Jun 17, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Souad AssaadJean-Yves Blay
Jun 27, 2020·Pediatric Blood & Cancer·Bradley GampelStephen S Roberts
Jun 27, 2020·Pediatric Blood & Cancer·Yang-Yang DingStephen P Hunger
Jul 4, 2020·Pediatric Blood & Cancer·Nicolas André
Sep 8, 2020·Pediatric Blood & Cancer·Jérémie Rouger-GaudichonVirginie Gandemer

❮ Previous
Next ❯

Citations

May 15, 2021·American Society of Clinical Oncology Educational Book·Daniel C MoreiraDouglas S Hawkins
Aug 30, 2021·The Lancet Oncology·Sheena MukkadaUNKNOWN Global Registry of COVID-19 in Childhood Cancer
Feb 25, 2021·Journal of Pediatric Hematology/oncology·Gabriel Revon-RiviereNicolas André

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Clinical Trials Mentioned

NCT04433871

Software Mentioned

PEDONCOVID

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.